VIM and colorectal carcinoma: The methylation of MGMT, hMLH1, and vimentin were detected, respectively, in 51.7, 30.0, and 38.3% of CRC, and in 36.5, 11, and 15.4% of colorectal adenomas, in combination the sensitivity were 75 and 59.6%.